Global Pediatric Vaccines Market Insights, Forecast to 2025

  • ID:PD007168
  • October 2019
  • QY Research
                          

Pediatric Vaccines Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Pediatric Vaccines Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Pediatric Vaccines market.
 
This research report categorizes the global Pediatric Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
 
In 2017, the global Pediatric Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Pediatric Vaccines market based on company, product type, application and key regions.
 
The various contributors involved in the value chain of Pediatric Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pediatric Vaccines include

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Novartis
  • Takeda Pharmaceutical
  • Bavarian Nordic
  • Baxter
  • LG Life Sciences
  • Lupin
  • S K Chemicals
  • Mitsubishi Tanabe Pharma
  • Janssen
Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • Bharat Biotech
  • Crucell
  • Dynavax
  • Serum Institute of India
Market Size Split by Type
  • Diphtheria
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Meningococcal Diseases
  • Others
Market Size Split by Application
  • Newborn
  • Infant
  • Child
  • Dolescent
Market size split by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
The study objectives of this report are:
  • To study and analyze the global Pediatric Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Pediatric Vaccines market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Pediatric Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Pediatric Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Pediatric Vaccines submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents - Guidelines
1 Study Coverage
1.1  Pediatric Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pediatric Vaccines Market Size Growth Rate by Type
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Others
1.5 Market by Application
1.5.1 Global Pediatric Vaccines Market Size Growth Rate by Application
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.5.5 Dolescent
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Vaccines Market Size
2.1.1 Global Pediatric Vaccines Revenue 2016-2025
2.1.2 Global Pediatric Vaccines Sales 2016-2025
2.2 Pediatric Vaccines Growth Rate by Regions
2.2.1 Global Pediatric Vaccines Sales by Regions
2.2.2 Global Pediatric Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pediatric Vaccines Sales by Manufacturers
3.1.1 Pediatric Vaccines Sales by Manufacturers
3.1.2 Pediatric Vaccines Sales Market Share by Manufacturers
3.1.3 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Vaccines Revenue by Manufacturers
3.2.1 Pediatric Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 Pediatric Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 Pediatric Vaccines Price by Manufacturers
3.4 Pediatric Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into Pediatric Vaccines  Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Pediatric Vaccines Sales by Type
4.2 Global Pediatric Vaccines Revenue by Type
4.3 Pediatric Vaccines Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Pediatric Vaccines Breakdown Data by Application
6 North America
6.1 North America Pediatric Vaccines by Countries
6.1.1 North America Pediatric Vaccines Sales by Countries
6.1.2 North America Pediatric Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pediatric Vaccines by Type
6.3 North America Pediatric Vaccines by Application
6.4 North America Pediatric Vaccines by Company
7 Europe
7.1 Europe Pediatric Vaccines by Countries
7.1.1 Europe Pediatric Vaccines Sales by Countries
7.1.2 Europe Pediatric Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatric Vaccines by Type
7.3 Europe Pediatric Vaccines by Application
7.4 Europe Pediatric Vaccines by Company
8 Asia Pacific
8.1 Asia Pacific Pediatric Vaccines by Countries
8.1.1 Asia Pacific Pediatric Vaccines Sales by Countries
8.1.2 Asia Pacific Pediatric Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pediatric Vaccines by Type
8.3 Asia Pacific Pediatric Vaccines by Application
8.4 Asia Pacific Pediatric Vaccines by Company
9 Central & South America
9.1 Central & South America Pediatric Vaccines by Countries
9.1.1 Central & South America Pediatric Vaccines Sales by Countries
9.1.2 Central & South America Pediatric Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pediatric Vaccines by Type
9.3 Central & South America Pediatric Vaccines by Application
9.4 Central & South America Pediatric Vaccines by Company
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Vaccines by Countries
10.1.1 Middle East and Africa Pediatric Vaccines Sales by Countries
10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pediatric Vaccines by Type
10.3 Middle East and Africa Pediatric Vaccines by Application
10.4 Middle East and Africa Pediatric Vaccines by Company
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.1.4 Pediatric Vaccines Product Description
11.1.5 Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.2.4 Pediatric Vaccines Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.3.4 Pediatric Vaccines Product Description
11.3.5 Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.4.4 Pediatric Vaccines Product Description
11.4.5 Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.5.4 Pediatric Vaccines Product Description
11.5.5 Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.6.4 Pediatric Vaccines Product Description
11.6.5 Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.7.4 Pediatric Vaccines Product Description
11.7.5 Recent Development
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.8.4 Pediatric Vaccines Product Description
11.8.5 Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.9.4 Pediatric Vaccines Product Description
11.9.5 Recent Development
11.10 LG Life Sciences
11.10.1 LG Life Sciences Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Pediatric Vaccines
11.10.4 Pediatric Vaccines Product Description
11.10.5 Recent Development
11.11 Lupin
11.12 S K Chemicals
11.13 Mitsubishi Tanabe Pharma
11.14 Janssen
11.15 Shenzhen Kangtai Biological Products
11.16 Sinovac Biotech
11.17 Bharat Biotech
11.18 Crucell
11.19 Dynavax
11.20 Serum Institute of India
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Pediatric Vaccines Raw Material
13.1.2 Pediatric Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..